Last week, I received an update from Personalized Stem Cells, Inc. indicating that the trial submission to the FDA concerning a third Adipose-Derived Mesenchymal Stem Cell Study for the arthritic knee would take place in late September or early October. You may learn more about the Trials completed or planned by visiting www.Personalizedstemcells.com or by following my future blog postings.
Adipose-Derived Mesenchymal Stem Cells
Shortly after the discovery of the hematopoietic stem cell by Till and McCulloch, a scientist named Alexander Friedenstein discovered mesenchymal stem cells (MSCs) in bone marrow. But it would be several decades before MSCs were discovered in adipose tissue. Though there are multiple types of stem cells, PSC works exclusively with MSCs (You can learn more about MSCs in this blog.) More specifically, we work with adipose (fat) derived mesenchymal stem cells.
Since the discovery of adipose-derived stem cells (ADSCs) in the early 21st century, they have been a hot topic of study. Numerous studies all over the world have evaluated the use of ADSCs in various disease categories ranging from orthopedics, autoimmune disorders, and even respiratory diseases such as COVID-19.
We Must Continue to Research
In the grand scheme of things, ADSCs are relatively new to the stem cell playing field and thus, more research is necessary to determine the safety and efficacy of such treatments. The FDA strictly regulates cell-based therapies and to this day, there are no FDA-approved fat-derived stem cell products on the market. But the research and results continue to accumulate via various FDA-approved clinical trials. We are fortunate enough to contribute to this research with our own FDA-approved clinical trials and resulting data. We hope to one day see adipose-derived stem cell therapy become a readily available and easily accessible treatment for those who may benefit from it.
Stem Cell Institute of America sued, accused of falsely marketing treatments for ortho pain
Alan Condon – Wednesday, August 18th, 2021
The co-founders of the Stem Cell Institute of America are being sued, accused of marketing stem cell therapy to seniors by falsely claiming that it is an effective treatment for orthopedic conditions such as arthritis and joint pain.
The lawsuit, filed Aug. 17 by the Federal Trade Commission and the Georgia attorney general, alleges that defendants Steven Peyroux and Brent Detelich “promoted the false or unsubstantiated claim that stem cell therapy is comparable or superior to surgery, steroid injections and painkillers,” the FTC said in a news release.
The defendants also provided marketing materials and training to chiropractors that deceived consumers about the results of stem cell therapies, according to the complaint.
Evidence-Based Regenerative Medicine
The goal of my evidence-based practice is to eliminate unsound and illegal practices by shifting my decision-making from tradition, intuition, and unsystematic experience to firmly grounded scientific research. To learn if I might minimize, perhaps eliminate your arthritic symptoms and improve your function with a needle, not a knife schedule an office visit by calling (312) 475-1893. You may visit my website www.sheinkopmd.com.